Annemieke Th. den Boer

Author

Also Known As

A T den Boer, A. Th. den Boer, A.T. Den Boer, A.Th. den Boer, Annemieke T den Boer, Annemieke TH. Den Boer, Annemieke Th den Boer, Annemieke Th. den Boer

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

Leiden University Medical Center Radboud University Nijmegen The Netherlands Cancer Institute Maastricht University Institute of Haematology and Blood Transfusion

About

Annemieke Th. den Boer is an author at Leiden University Medical Center specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	535
2	Public Health	1	1	44
3	Allergy	1	1	457
4	Cell Biology	1	1	10
5	Diabetes	1	1	44

Annemieke Th. den Boer

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy Linda Diehl, Annemieke Th. den Boer, Stephen P. Schoenberger, Nature Medicine Tumor ImmunologyAutoimmune DiseaseAllergyImmunologyAntigen Processing	1999	457
Cytotoxic T cells are able to efficiently eliminate cancer cells by additive cytotoxicity Bettina Weigelin, Annemieke Th. den Boer, Esther Wagena, Nature Communications	2021	226
CD40 stimulation leads to effective therapy of CD40<sup>−</sup>tumors through induction of strong systemic cytotoxic T lymphocyte immunity Geertje J. D. van Mierlo, Annemieke Th. den Boer, Jan Paul Medema, Proceedings of the National Academy of Sciences	2002	220
Activation of Dendritic Cells That Cross-Present Tumor-Derived Antigen Licenses CD8+ CTL to Cause Tumor Eradication Geertje J. D. van Mierlo, Zita F. H. M. Boonman, Hélène Dumortier, The Journal of Immunology	2004	167
Importance of Weight Loss Maintenance and Risk Prediction in the Prevention of Type 2 Diabetes: Analysis of European Diabetes Prevention Study RCT Linda Penn, Martin White, Jaana Lindström, PLoS ONE	2013	141
Angelman syndrome in adulthood Laura Laan, Annemieke Th. den Boer, Raoul C. M. Hennekam, American Journal of Medical Genetics	1996	139
In Vivo Triggering Through 4-1BB Enables Th-Independent Priming of CTL in the Presence of an Intact CD28 Costimulatory Pathway Linda Diehl, Geertje J. D. van Mierlo, Annemieke Th. den Boer, The Journal of Immunology	2002	90
Longevity of Antigen Presentation and Activation Status of APC Are Decisive Factors in the Balance Between CTL Immunity Versus Tolerance Annemieke Th. den Boer, Linda Diehl, Geertje J. D. van Mierlo, The Journal of Immunology	2001	67
Prevention of the metabolic syndrome in IGT subjects in a lifestyle intervention: Results from the SLIM study Annemieke Th. den Boer, Ingrid J.T. Herraets, Jos H. C. H. Stegen, Nutrition Metabolism and Cardiovascular Diseases ObesityNutritionMetabolic SyndromeSlim StudyLifestyle Modification	2013	44
The Tumoricidal Activity of Memory CD8+ T Cells Is Hampered by Persistent Systemic Antigen, but Full Functional Capacity Is Regained in an Antigen-Free Environment Annemieke Th. den Boer, Geertje J. D. van Mierlo, Marieke F. Fransen, The Journal of Immunology	2004	41

Page 1